Monitoring of Metabolic, Cardiac, and Endocrine Indicators in Youth Treated With Antipsychotics as Reported by Health Care Professionals

Monitoring of Adverse Drug Reaction-Related Parameters in Children, Youth, and Young Adults Prescribed Antipsychotic Drugs by General Practitioners

Minjon, Lenneke
van den Ban, Els
Bazelier, Marloes T
Lalmohamed, Arief
Egberts, Toine C G
Heerdink, Eibert R

February 2022

Objective: The aim of the study was to assess monitoring of adverse drug reaction (ADR)-related para...

Cardiovascular Monitoring of Children and Adolescents Receiving Psychotropic Drugs A Statement for Healthcare Professionals From the Committee on Congenital Cardiac Defects,

Council Cardiovascular
Disease Young
Robert Shaddy
Members Kathryn A. Taubert
Aha Staff

October 2016

Reports of sudden deaths of children and adolescents treated with psychotropic medications have rais...

Child and Adolescent Psychiatrists\u27 Reported Monitoring Behaviors for Second-Generation Antipsychotics

Rodday, A. M.
Parsons, S. K.
Mankiw, C.
Correll, C. U.
Robb, A. S.
Zima, B. T.
Saunders, T. S.
Leslie, L. K.

January 2015

Objective: The number of children and adolescents (hereafter referred to as children ) who have bee...

Monitoring of Metabolic, Cardiac, and Endocrine Indicators in Youth Treated With Antipsychotics as Reported by Health Care Professionals

Minjon, Lenneke
van den Ban, Els
de Jong, Emma
Egberts, Toine C G
Heerdink, Eibert R

January 2018

BACKGROUND: It is unclear how youth treated with antipsychotics are monitored. The purpose of this s...

Monitoring of metabolic, cardiac, and endocrine indicators in youth treated with antipsychotics as reported by health care professionals

Minjon, Lenneke
van den Ban, Els
de Jong, Emma
Egberts, Toine C G
Heerdink, Eibert R

January 2018

BACKGROUND: It is unclear how youth treated with antipsychotics are monitored. The purpose of this s...

Improving metabolic monitoring rate for young people aged 35 and younger taking antipsychotic medications to treat a psychosis: A literature review

Chee, G.
Wynaden, Dianne
Heslop, K.

January 2017

Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents A systematic review of randomized, placebo controlled trials and guidelines for clinical practice

De Hert, Marc
Dobbelaere, M
Sheridan, E
Cohen, D
Correll, C

April 2011

Second-generation antipsychotics (SGA) are being used more often than ever before in children and ad...

Monitoring of Adverse Drug Reaction-Related Parameters in Children and Adolescents Treated With Antipsychotic Drugs in Psychiatric Outpatient Clinics

Minjon, Lenneke
Brozina, Ivona
Egberts, Toine C G
Heerdink, Eibert R
van den Ban, Els

February 2021

Aim: To assess the frequency of monitoring of adverse drug reaction (ADR) related parameters in chil...

Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents:A systematic review of randomized, placebo controlled trials and guidelines for clinical practice

De Hert, M.
Dobbelaere, M.
Sheridan, E. M.
Cohen, D.
Correll, C. U.

April 2011

Second-generation antipsychotics (SGA) are being used more often than ever before in children and ad...

Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: A systematic review of randomized, placebo controlled trials and guidelines for clinical practice

De Hert, M.
Dobbelaere, M.
Sheridan, E. M.
Cohen, D.
Correll, C. U.

April 2011

Second-generation antipsychotics (SGA) are being used more often than ever before in children and ad...

Risperidone and Cardiometabolic Risk in Children and Adolescents: Clinical and Instrumental Issues

Matera, Emilia
Margari, Lucia
Palmieri, Vincenzo Ostilio
Zagaria, Giuseppina
Palumbi, Roberto
Margari, Francesco

January 2017

PURPOSE/BACKGROUND: Although second-generation antipsychotics are used to treat and manage symptoms ...

Metabolic and cardiovascular adverse effects associated with antipsychotic drugs

De Hert, Marc
Detraux, Johan
van Winkel, Ruud
Yu, Weiping
Correll, Christoph

January 2012

Antipsychotic medications can induce cardiovascular and metabolic abnormalities (such as obesity, hy...

Child and Adolescent Psychiatrists' Reported Monitoring Behaviors for Second-Generation Antipsychotics

Rodday, Angie Mae
Parsons, Susan K
Mankiw, Catherine
Correll, Christoph U
Robb, Adelaide S
Zima, Bonnie T
Saunders, Tully S
Leslie, Laurel K

May 2015

ObjectiveThe number of children and adolescents (hereafter referred to as "children") who have been ...

Monitoring of Adverse Drug Reaction-Related Parameters in Children, Youth, and Young Adults Prescribed Antipsychotic Drugs by General Practitioners

Minjon, Lenneke
van den Ban, Els
Bazelier, Marloes T
Lalmohamed, Arief
Egberts, Toine C G
Heerdink, Eibert R

February 2022

Objective: The aim of the study was to assess monitoring of adverse drug reaction (ADR)-related para...

Cardiovascular Monitoring of Children and Adolescents Receiving Psychotropic Drugs A Statement for Healthcare Professionals From the Committee on Congenital Cardiac Defects,

Council Cardiovascular
Disease Young
Robert Shaddy
Members Kathryn A. Taubert
Aha Staff

October 2016

Reports of sudden deaths of children and adolescents treated with psychotropic medications have rais...

Child and Adolescent Psychiatrists\u27 Reported Monitoring Behaviors for Second-Generation Antipsychotics

Rodday, A. M.
Parsons, S. K.
Mankiw, C.
Correll, C. U.
Robb, A. S.
Zima, B. T.
Saunders, T. S.
Leslie, L. K.

January 2015

Objective: The number of children and adolescents (hereafter referred to as children ) who have bee...

Monitoring of Metabolic, Cardiac, and Endocrine Indicators in Youth Treated With Antipsychotics as Reported by Health Care Professionals

Minjon, Lenneke
van den Ban, Els
de Jong, Emma
Egberts, Toine C G
Heerdink, Eibert R

January 2018

BACKGROUND: It is unclear how youth treated with antipsychotics are monitored. The purpose of this s...

Monitoring of metabolic, cardiac, and endocrine indicators in youth treated with antipsychotics as reported by health care professionals

Minjon, Lenneke
van den Ban, Els
de Jong, Emma
Egberts, Toine C G
Heerdink, Eibert R

January 2018

BACKGROUND: It is unclear how youth treated with antipsychotics are monitored. The purpose of this s...

Improving metabolic monitoring rate for young people aged 35 and younger taking antipsychotic medications to treat a psychosis: A literature review

Chee, G.
Wynaden, Dianne
Heslop, K.

January 2017

Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents A systematic review of randomized, placebo controlled trials and guidelines for clinical practice

De Hert, Marc
Dobbelaere, M
Sheridan, E
Cohen, D
Correll, C

April 2011

Second-generation antipsychotics (SGA) are being used more often than ever before in children and ad...

Monitoring of Adverse Drug Reaction-Related Parameters in Children and Adolescents Treated With Antipsychotic Drugs in Psychiatric Outpatient Clinics

Minjon, Lenneke
Brozina, Ivona
Egberts, Toine C G
Heerdink, Eibert R
van den Ban, Els

February 2021

Aim: To assess the frequency of monitoring of adverse drug reaction (ADR) related parameters in chil...

Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents:A systematic review of randomized, placebo controlled trials and guidelines for clinical practice

De Hert, M.
Dobbelaere, M.
Sheridan, E. M.
Cohen, D.
Correll, C. U.

April 2011

Second-generation antipsychotics (SGA) are being used more often than ever before in children and ad...

Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: A systematic review of randomized, placebo controlled trials and guidelines for clinical practice

De Hert, M.
Dobbelaere, M.
Sheridan, E. M.
Cohen, D.
Correll, C. U.

April 2011

Second-generation antipsychotics (SGA) are being used more often than ever before in children and ad...

Risperidone and Cardiometabolic Risk in Children and Adolescents: Clinical and Instrumental Issues

Matera, Emilia
Margari, Lucia
Palmieri, Vincenzo Ostilio
Zagaria, Giuseppina
Palumbi, Roberto
Margari, Francesco

January 2017

PURPOSE/BACKGROUND: Although second-generation antipsychotics are used to treat and manage symptoms ...

Metabolic and cardiovascular adverse effects associated with antipsychotic drugs

De Hert, Marc
Detraux, Johan
van Winkel, Ruud
Yu, Weiping
Correll, Christoph

January 2012

Antipsychotic medications can induce cardiovascular and metabolic abnormalities (such as obesity, hy...

Child and Adolescent Psychiatrists' Reported Monitoring Behaviors for Second-Generation Antipsychotics

Rodday, Angie Mae
Parsons, Susan K
Mankiw, Catherine
Correll, Christoph U
Robb, Adelaide S
Zima, Bonnie T
Saunders, Tully S
Leslie, Laurel K

May 2015

ObjectiveThe number of children and adolescents (hereafter referred to as "children") who have been ...

Monitoring of Adverse Drug Reaction-Related Parameters in Children, Youth, and Young Adults Prescribed Antipsychotic Drugs by General Practitioners

Minjon, Lenneke
van den Ban, Els
Bazelier, Marloes T
Lalmohamed, Arief
Egberts, Toine C G
Heerdink, Eibert R

February 2022

Objective: The aim of the study was to assess monitoring of adverse drug reaction (ADR)-related para...

Cardiovascular Monitoring of Children and Adolescents Receiving Psychotropic Drugs A Statement for Healthcare Professionals From the Committee on Congenital Cardiac Defects,

Council Cardiovascular
Disease Young
Robert Shaddy
Members Kathryn A. Taubert
Aha Staff

October 2016

Reports of sudden deaths of children and adolescents treated with psychotropic medications have rais...

Child and Adolescent Psychiatrists\u27 Reported Monitoring Behaviors for Second-Generation Antipsychotics

Rodday, A. M.
Parsons, S. K.
Mankiw, C.
Correll, C. U.
Robb, A. S.
Zima, B. T.
Saunders, T. S.
Leslie, L. K.

January 2015

Objective: The number of children and adolescents (hereafter referred to as children ) who have bee...

Monitoring of Metabolic, Cardiac, and Endocrine Indicators in Youth Treated With Antipsychotics as Reported by Health Care Professionals

Abstract

Extracted data

Monitoring of Metabolic, Cardiac, and Endocrine Indicators in Youth Treated With Antipsychotics as Reported by Health Care Professionals

Abstract

Extracted data

Related items

Related items